Paula N. Njeru
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paula N. Njeru has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- Deborah Koltai Attix
Duke Division of Global Neurosurgery and Neurology, Department of Neurosurgery, Box 3807 Duke University Medical Center, Durham, NC 27705, USA; Duke Global Health Institute, 310 Trent Dr, Durham, NC 27710, USA; Duke University School of Medicine, Department of Neurosurgery, Durham, NC, USA
4 shared publications - Angelina Kakooza-Mwesige
Department of Pediatrics and Child Health Makerere University Kampala Uganda
3 shared publications Abubakar M. Mohammed
2 shared publications- Alvan-Emeka Kelechi Ukachukwu
Department of Neurosurgery, Duke University Health System, Durham, USA
2 shared publications - Anthony T. Fuller
Duke University Division of Global Neurosurgery and Neurology, Durham, NC, USA; Department of Internal Medicine, Johns Hopkins Medicine, Baltimore, MD, USA; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA
2 shared publications Bamidele O. Adebayo
2 shared publications
Latest Publications
- 26 October 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 186
Pilot testing an epilepsy self-management and resilience smartphone application for adolescents and young adults in Uganda
- 26 October 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 186
Pilot testing an epilepsy self-management and resilience smartphone application for adolescents and young adults in Uganda
- Open Access
- 4 July 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 183, 111167
Explanatory models of epilepsy: key deterrents to seeking biomedical care and effective epilepsy management in Uganda
- 4 July 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 183, 111167
Open AccessExplanatory models of epilepsy: key deterrents to seeking biomedical care and effective epilepsy management in Uganda
- Open Access
- 8 April 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 180, 111021
Community perspectives and recommendations to reduce epilepsy stigma and enhance effective management of epilepsy in Uganda: A qualitative study
- 8 April 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 180, 111021
Open AccessCommunity perspectives and recommendations to reduce epilepsy stigma and enhance effective management of epilepsy in Uganda: A qualitative study
Population‐based prevalence of epilepsy in Uganda: A nationwide cross‐sectional survey
Objective: Establishing the prevalence of epilepsy in Uganda is crucial to inform interventions and public policy. We conducted a nationwide survey to determine epilepsy prevalence. Methods: From January 2019 to July 2022, a door‐to‐door survey was conducted across all four regions of Uganda, targeting a nationally representative sample of households. Trained field teams identified and interviewed heads of households to obtain demographic information, and three household members were randomly selected for epilepsy screening. A two‐part survey, adapted from a validated standardized epilepsy questionnaire in low‐ and middle‐income countries, was used for screening. To ensure the accuracy of the prevalence estimates, a subset of screened individuals underwent clinical validation by a qualified neurologist. Epilepsy was defined per the International League Against Epilepsy (ILAE) criteria. We employed Monte Carlo simulation to extrapolate prevalence estimates. Results: We identified and screened 35 055 participants (53.5% female). The ages ranged from 1 month to 108 years, with a mean age of 20.7 years. The overall crude epilepsy prevalence was estimated at 16.9 per 1000 persons, with an age‐ and sex‐adjusted prevalence rate of 17.8 per 1000. The differences in sex‐specific prevalence rates were not statistically significant. The highest age‐specific prevalence rate of 25.0 per 1000 occurred in the 20‐ to 39 ‐year age group. There was a substantial variation in epilepsy prevalence across the various regions, with the highest prevalence recorded in the eastern region and the lowest in the northern region. Significance: Our study underscores the high epilepsy burden in Uganda, particularly among adults, and reveals age, gender, and geographical variation likely arising from disparities in the underlying determinants. Identification of these factors is crucial for addressing treatment gaps and reducing epilepsy prevalence.
Population‐based prevalence of epilepsy in Uganda: A nationwide cross‐sectional survey
Objective: Establishing the prevalence of epilepsy in Uganda is crucial to inform interventions and public policy. We conducted a nationwide survey to determine epilepsy prevalence. Methods: From January 2019 to July 2022, a door‐to‐door survey was conducted across all four regions of Uganda, targeting a nationally representative sample of households. Trained field teams identified and interviewed heads of households to obtain demographic information, and three household members were randomly selected for epilepsy screening. A two‐part survey, adapted from a validated standardized epilepsy questionnaire in low‐ and middle‐income countries, was used for screening. To ensure the accuracy of the prevalence estimates, a subset of screened individuals underwent clinical validation by a qualified neurologist. Epilepsy was defined per the International League Against Epilepsy (ILAE) criteria. We employed Monte Carlo simulation to extrapolate prevalence estimates. Results: We identified and screened 35 055 participants (53.5% female). The ages ranged from 1 month to 108 years, with a mean age of 20.7 years. The overall crude epilepsy prevalence was estimated at 16.9 per 1000 persons, with an age‐ and sex‐adjusted prevalence rate of 17.8 per 1000. The differences in sex‐specific prevalence rates were not statistically significant. The highest age‐specific prevalence rate of 25.0 per 1000 occurred in the 20‐ to 39 ‐year age group. There was a substantial variation in epilepsy prevalence across the various regions, with the highest prevalence recorded in the eastern region and the lowest in the northern region. Significance: Our study underscores the high epilepsy burden in Uganda, particularly among adults, and reveals age, gender, and geographical variation likely arising from disparities in the underlying determinants. Identification of these factors is crucial for addressing treatment gaps and reducing epilepsy prevalence.
- 9 May 2024
- Published by Elsevier in World Neurosurgery
- Vol. 185, e30-e43
Assessing the Neurosurgical Capacity in Nigeria Using the Modified Neuro-PIPES Tool
- 9 May 2024
- Published by Elsevier in World Neurosurgery
- Vol. 185, e30-e43
Assessing the Neurosurgical Capacity in Nigeria Using the Modified Neuro-PIPES Tool